FindTrial
Sign In

oral DHEAS on health of women with Sheehans syndrome

A randomized controlled trial study on role of DHEAS in patients with Sheehan�s syndrome attending a tertiary care hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/11/010635
Enrollment
30
Registered
2017-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E230- Hypopituitarism Health Condition 2: null- stable

Interventions

Intervention1: oral Dehydroepiandrosteronesulphate (DHEAS) 75 mg sustained release: The patients of Sheehans syndrome will be first evaluated for sexual function & quality of life (QoL) by standard qu

Sponsors

IPGMER kolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of Sheehanââ?¬•s Syndrome 2. Subjects having both low level of DHEAS & sexual dysfunction &/or impaired quality of life

Exclusion criteria

Exclusion criteria: 1.Patients having hypopituitarism due to any cause other than SS 2.Patients having any other chronic disease e.g CKD, CLD, DM etc

Design outcomes

Primary

MeasureTime frame
To see the effect of DHEAS after its replacement in sexual function & QoL in patients having both low DHEAS as well as sexual dysfunction &/ or impaired QoL.Timepoint: at 0( before giving intervention), at the end of 12 th week & at the end of 26 th week—

Secondary

MeasureTime frame
noneTimepoint: none—

Countries

India

Contacts

Public ContactDr Soumita Manda

Associate Professor, Dept of Endocrinology, IPGME&R, kolkata

pradip.mukherjee@gmail.com9674410302

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026